<DOC>
	<DOCNO>NCT03054610</DOCNO>
	<brief_summary>Plantar fasciitis common cause plantar heel pain commonly present people 40 year age old , overweight , sedentary intense physical activity . It cause over-stretching plantar fascia , band connective tissue extend base phalanx . This produce micro-tears commonly origin medial tuberosity calcaneus cause inflammatory process pain . This pain usually occur person get morning sleep sit long time . That fascia stretch contraction position . There great variety treatment pathology , , one common use intralesional steroid , weigh reduces symptomatology many case also undesirable effect subcutaneous fat atrophy , rupture plantar fascia , peripheral nerve injury , muscle damage stress fracture . Other treatment extracorporeal shock wave , application platelet-rich plasma application botulinum toxin A intralesional . All accompanied insole , night splint stretch exercise Achilles tendon plantar fascia . Recent study show application botulinum toxin A intralesional patient plantar fasciitis help improve symptomatology decrease pain intensity presentation time . Decreased inflammation plantar fascia also demonstrate . This sale usual form action botulinum toxin , apply regularly muscle block release acetylcholine neuromuscular plaque obtain relaxation directly pain point . We believe botulinum toxin apply intralesional currently , since information toxin analgesic anti-inflammatory effect muscle relaxation . The aim work demonstrate use botulinum toxin A intralesional stretching exercise superior intralesional steroid stretch try establish safe less painful therapy avoid complication prior application steroid application .</brief_summary>
	<brief_title>Therapeutic Effect Botulinum Toxin A Treatment Plantar Fasciitis .</brief_title>
	<detailed_description>Plantar fasciitis represent frequent cause chronic heel pain , usually occur patient 40 year old , overweight , sedentary intense physical activity . The plantar fascia function prevent foot collapse anatomical orientation tensile force ; It originate base calcaneus extend distally phalanx . The plantar fascia stretch prevents displacement calcaneus metatarsal maintain medial longitudinal arch . Simulates cable attach calcaneus metatarsophalangeal joint . The windlass mechanism describe Hicks , action plantar fascia usually explain dorsiflexion finger occur , lead effective shorten length plantar fascia cause elevation arch . The extension finger increase arch tension metatarsophalangeal joint axis anchor point . The shorten plantar fascia result dorsiflexion hallux essence windlass mechanism . When fasciotomy perform , mechanism lose , decrease stability arch allow phase stable terminal stay . Historically development plantar fasciitis attribute biomechanical defect hyperpronation , contribute excesive mobility foot , increase stress apply musculofascial structure soft tissue elongation plantar fascia . There study show one main factor appearance disease mechanical overload report tension necessary rupture windlass mechanism range 1.4 3.4 body weight subject . There great variety therapy report treatment pathology , intralesional application steroid , platelet-rich plasma , intralesional botulinum toxin A , treatment extracorporeal shock wave , assist stretch excercises gastrocnemius sole muscle stretch plantar fascia . The clinical use botulinum toxin A expand beyond original indication effect cholinergic neuron . The increased interest potential role treat condition chronic pain partially base effect toxin modulation release substance P , calcitonin-related gene peptide glutamate . On hand , toxin show effect inhibition inflamatory pain release neurotransmitter primary sensory neuron rat model . It also inhibit peripheral sensitization , lead indirect decrease central sensitization . It unclear whether treatment chronic plantar fasciitis botulinum toxin A work cause muscle paralysis analgesic anti-inflamatory effect mechanism . A combined effect , induction paresia muscle originate medial calcaneus process direct analgesia due analgesic anti-inflamatory property . We perform previous study , compare use botulinum toxin A intralesional steroid ; The application botulinum toxin A perform twin sole muscle womb , dexamethasone apply area great fascia pain . Patients receive botulinum toxin faster sustained improvement patient receive steroid . Another common form treatment plantar fasciitis application intralesional steroid ; however , report complication associate drug one main one rupture plantar fascia , range 2.4 % 5.7 % ; Despite pain relief due rupture , many patient associated complication lateral plantar nerve dysfunction , stress fracture , among others , mainly 2 application . Objective originality : The aim study demonstrate use botulinum toxin A treatment plantar fasciitis superior treatment intralesional steroid . We try establish safe less painful treatment therapy patient , since use steroid associate complication . We believe botulinum toxin A also apply intralesional , since information indicate toxin analgesic anti-inflammatory effect local application action muscle relaxation block release acetylcholine neuromuscular junction . General objective : To assess therapeutic effect botulinum toxin A patient diagnosed plantar fasciitis . Hypothesis : The application botulinum toxin A present well result treatment plantar fascitis use intralesional steroid . Material Methods : All patient recruit study explain regard treatment protocol , also sign informed consent prior inclusion study . Measurement plantar fascia use ultrasound measurement range movement ankle flexion , well measure weigh patient know body mass index . They randomize one three treatment group . Group 1 ( control ) treatment 5 ml anesthetic ( Ropivacaine 7.5 % ) , Group 2 ( steroid ) application 1ml Betamethasone plus 3 ml local anesthetic Group 3 ( botulinum toxin A ) 250 U , insertion zone plantar fascia . All patient receive detailed explanation stretch exercise plantar fascia , well frequency duration . Afterwards , patient evaluate blinded investigator , 2 week , 1 month , 3 month 6 month infiltration ; evaluation scale apply : Visual Analogue Scale ( EVA ) , Maryland Foot &amp; Ankle Score , Foot &amp; Ankle Outcome Score ( AOFAS ) , Foot &amp; Ankle Disability Index ( FADI ) .</detailed_description>
	<mesh_term>Fasciitis</mesh_term>
	<mesh_term>Fasciitis , Plantar</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone acetate phosphate</mesh_term>
	<criteria>Patients chronic pain heel insertion plantar fascia posteroinferior tuberosity calcaneus . Patients agree part study sign informed consent . Patients older 18 year . Patients two week evolution . Patients another associated pathology knee ankle dysfunction , osteoarthritis , rheumatoid arthritis , ankylose spondylitis , etc . Neurological abnormality : mental retardation psychiatric abnormality . Pregnant patient . Previous surgery heel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>plantar fascitis</keyword>
	<keyword>Botulinum toxin A</keyword>
	<keyword>Betamethason Sodium Phosphate</keyword>
	<keyword>infiltration</keyword>
	<keyword>plantar fascia</keyword>
</DOC>